Fig. 7From: Bioprospecting of desert actinobacteria with special emphases on griseoviridin, mitomycin C and a new bacterial metabolite producing Streptomyces sp. PU-KB10–4a % Viability of A549 (non-small lung) and PC3 (prostate) human cancer cell lines (after 72 h) at 80 μM concentration of compounds 1–3. b Dose-response of compounds 1–3 against A549 (non-small cell lung) human cancer cell line (72 h). (c) Dose-response of compounds 1–3 against PC3 (prostate) human cancer cell line (72 h). A549: IC50 for the compounds 1 ((> 80 μM), 2 (1.06 ± 0.04 μM) and 3 (> 80 μM). PC3: IC50 for the compounds 1 (> 80 μM), 2 (3.04 ± 0.25 μM) and 3 (> 80 μM)Back to article page